annual CFI:
-$20.82B-$18.81B(-936.34%)Summary
- As of today (May 29, 2025), ABBV annual cash flow from investing activities is -$20.82 billion, with the most recent change of -$18.81 billion (-936.34%) on December 31, 2024.
- During the last 3 years, ABBV annual CFI has fallen by -$18.48 billion (-788.23%).
- ABBV annual CFI is now -2468.60% below its all-time high of $879.00 million, reached on December 31, 2013.
Performance
ABBV Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
-$735.00M+$1.14B(+60.78%)Summary
- As of today (May 29, 2025), ABBV quarterly cash flow from investing activities is -$735.00 million, with the most recent change of +$1.14 billion (+60.78%) on March 1, 2025.
- Over the past year, ABBV quarterly CFI has increased by +$8.85 billion (+92.33%).
- ABBV quarterly CFI is now -129.24% below its all-time high of $2.51 billion, reached on December 31, 2014.
Performance
ABBV quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$11.97B+$8.85B(+42.52%)Summary
- As of today (May 29, 2025), ABBV TTM cash flow from investing activities is -$11.97 billion, with the most recent change of +$8.85 billion (+42.52%) on March 1, 2025.
- Over the past year, ABBV TTM CFI has dropped by -$869.00 million (-7.83%).
- ABBV TTM CFI is now -1389.55% below its all-time high of $928.00 million, reached on September 30, 2019.
Performance
ABBV TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
ABBV Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -936.3% | +92.3% | -7.8% |
| 3 y3 years | -788.2% | +53.8% | -233.1% |
| 5 y5 years | -3593.3% | -469.8% | -2522.5% |
ABBV Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -3241.9% | at low | -157.2% | +92.3% | -2651.6% | +42.5% |
| 5 y | 5-year | -3593.3% | +44.6% | -157.2% | +97.9% | -2522.5% | +68.3% |
| alltime | all time | -2468.6% | +44.6% | -129.2% | +97.9% | -1389.5% | +68.3% |
ABBV Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$735.00M(-60.8%) | -$11.97B(-42.5%) |
| Dec 2024 | -$20.82B(+936.3%) | -$1.87B(-77.3%) | -$20.82B(+5.4%) |
| Sep 2024 | - | -$8.26B(+649.2%) | -$19.75B(+66.5%) |
| Jun 2024 | - | -$1.10B(-88.5%) | -$11.86B(+6.9%) |
| Mar 2024 | - | -$9.59B(+1098.5%) | -$11.10B(+452.4%) |
| Dec 2023 | -$2.01B(+222.5%) | -$800.00M(+116.8%) | -$2.01B(+21.2%) |
| Sep 2023 | - | -$369.00M(+8.2%) | -$1.66B(>+9900.0%) |
| Jun 2023 | - | -$341.00M(-31.7%) | -$2.00M(-100.4%) |
| Mar 2023 | - | -$499.00M(+11.4%) | $469.00M(-175.3%) |
| Dec 2022 | -$623.00M(-73.4%) | -$448.00M(-134.8%) | -$623.00M(-52.8%) |
| Sep 2022 | - | $1.29B(+889.2%) | -$1.32B(-59.0%) |
| Jun 2022 | - | $130.00M(-108.2%) | -$3.22B(-10.4%) |
| Mar 2022 | - | -$1.59B(+39.0%) | -$3.59B(+53.3%) |
| Dec 2021 | -$2.34B(-93.8%) | -$1.15B(+86.2%) | -$2.34B(+28.4%) |
| Sep 2021 | - | -$615.00M(+154.1%) | -$1.83B(-22.6%) |
| Jun 2021 | - | -$242.00M(-29.2%) | -$2.36B(-93.8%) |
| Mar 2021 | - | -$342.00M(-45.5%) | -$37.77B(+0.6%) |
| Dec 2020 | -$37.56B(-6401.5%) | -$627.00M(-45.4%) | -$37.56B(+0.0%) |
| Sep 2020 | - | -$1.15B(-96.8%) | -$37.55B(+7.2%) |
| Jun 2020 | - | -$35.65B(>+9900.0%) | -$35.02B(-7188.7%) |
| Mar 2020 | - | -$129.00M(-79.0%) | $494.00M(-17.1%) |
| Dec 2019 | $596.00M(-159.2%) | -$615.00M(-144.6%) | $596.00M(-35.8%) |
| Sep 2019 | - | $1.38B(-1084.3%) | $928.00M(-165.7%) |
| Jun 2019 | - | -$140.00M(+418.5%) | -$1.41B(+141.1%) |
| Mar 2019 | - | -$27.00M(-90.5%) | -$586.00M(-41.7%) |
| Dec 2018 | -$1.01B(+267.2%) | -$283.00M(-70.6%) | -$1.01B(+92.7%) |
| Sep 2018 | - | -$963.00M(-240.2%) | -$522.00M(-257.2%) |
| Jun 2018 | - | $687.00M(-253.7%) | $332.00M(-997.3%) |
| Mar 2018 | - | -$447.00M(-322.4%) | -$37.00M(-86.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | -$274.00M(-95.5%) | $201.00M(-284.4%) | -$274.00M(-53.9%) |
| Sep 2017 | - | -$109.00M(-134.3%) | -$594.00M(-13.2%) |
| Jun 2017 | - | $318.00M(-146.5%) | -$684.00M(-87.1%) |
| Mar 2017 | - | -$684.00M(+474.8%) | -$5.30B(-12.7%) |
| Dec 2016 | -$6.07B(-53.0%) | -$119.00M(-40.2%) | -$6.07B(-2.8%) |
| Sep 2016 | - | -$199.00M(-95.4%) | -$6.25B(+17.8%) |
| Jun 2016 | - | -$4.30B(+194.8%) | -$5.31B(-60.7%) |
| Mar 2016 | - | -$1.46B(+390.9%) | -$13.52B(+4.5%) |
| Dec 2015 | -$12.94B(+1297.0%) | -$297.00M(-139.9%) | -$12.94B(+27.8%) |
| Sep 2015 | - | $745.00M(-106.0%) | -$10.13B(-23.0%) |
| Jun 2015 | - | -$12.51B(+1333.1%) | -$13.15B(+1212.8%) |
| Mar 2015 | - | -$873.00M(-134.7%) | -$1.00B(+8.2%) |
| Dec 2014 | -$926.00M(-205.3%) | $2.51B(-210.1%) | -$926.00M(-72.1%) |
| Sep 2014 | - | -$2.28B(+536.2%) | -$3.32B(+66.1%) |
| Jun 2014 | - | -$359.00M(-55.0%) | -$2.00B(+42.1%) |
| Mar 2014 | - | -$797.00M(-748.0%) | -$1.41B(-259.8%) |
| Dec 2013 | $879.00M(-136.4%) | $123.00M(-112.8%) | $879.00M(+59.8%) |
| Sep 2013 | - | -$964.00M(-513.7%) | $550.00M(-288.4%) |
| Jun 2013 | - | $233.00M(-84.3%) | -$292.00M(-59.8%) |
| Mar 2013 | - | $1.49B(-821.8%) | -$727.00M(-69.9%) |
| Dec 2012 | -$2.42B(-537.3%) | -$206.00M(-88.6%) | -$2.42B(+42.0%) |
| Sep 2012 | - | -$1.81B(+794.1%) | -$1.70B(-395.1%) |
| Jun 2012 | - | -$202.00M(-1.0%) | $577.02M(+33.1%) |
| Mar 2012 | - | -$204.00M(-140.1%) | $433.64M(-21.6%) |
| Dec 2011 | $553.00M(-111.0%) | $508.92M(+7.3%) | $553.00M(+1154.7%) |
| Sep 2011 | - | $474.10M(-237.3%) | $44.08M(-110.2%) |
| Jun 2011 | - | -$345.38M(+308.1%) | -$430.02M(+408.1%) |
| Mar 2011 | - | -$84.64M | -$84.64M |
| Dec 2010 | -$5.03B(+934.4%) | - | - |
| Dec 2009 | -$486.36M | - | - |
FAQ
- What is AbbVie annual cash flow from investing activities?
- What is the all time high annual CFI for AbbVie?
- What is AbbVie annual CFI year-on-year change?
- What is AbbVie quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for AbbVie?
- What is AbbVie quarterly CFI year-on-year change?
- What is AbbVie TTM cash flow from investing activities?
- What is the all time high TTM CFI for AbbVie?
- What is AbbVie TTM CFI year-on-year change?
What is AbbVie annual cash flow from investing activities?
The current annual CFI of ABBV is -$20.82B
What is the all time high annual CFI for AbbVie?
AbbVie all-time high annual cash flow from investing activities is $879.00M
What is AbbVie annual CFI year-on-year change?
Over the past year, ABBV annual cash flow from investing activities has changed by -$18.81B (-936.34%)
What is AbbVie quarterly cash flow from investing activities?
The current quarterly CFI of ABBV is -$735.00M
What is the all time high quarterly CFI for AbbVie?
AbbVie all-time high quarterly cash flow from investing activities is $2.51B
What is AbbVie quarterly CFI year-on-year change?
Over the past year, ABBV quarterly cash flow from investing activities has changed by +$8.85B (+92.33%)
What is AbbVie TTM cash flow from investing activities?
The current TTM CFI of ABBV is -$11.97B
What is the all time high TTM CFI for AbbVie?
AbbVie all-time high TTM cash flow from investing activities is $928.00M
What is AbbVie TTM CFI year-on-year change?
Over the past year, ABBV TTM cash flow from investing activities has changed by -$869.00M (-7.83%)